SLC2A4 gene: a promising target for pharmacogenomics of insulin resistance

Author： Corrêa-Giannella Maria Lucia   Machado Ubiratan F  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.14, Iss.8, 2013-06, pp. : 847-850

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estrogen Receptor 1 Agonist PPT Stimulates Slc2a4 Gene Expression and Improves Insulin-Induced Glucose Uptake in Adipocytes

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 19, 2012-10 ,pp. : 2059-2069

Bentham Science Publishers

Access to resources Recommend Favorite

Sterol regulatory element-binding protein (SREBP)-1: gene regulatory target for insulin resistance?

By Kotzka Jorg   Müller-Wieland Dirk  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 2, 2004-04 ,pp. : 141-149

Informa Healthcare

Access to resources Recommend Favorite

NEDD4: A Promising Target for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. : 549-556

Bentham Science Publishers

Access to resources Recommend Favorite

CXCR4 Receptor as a Promising Target for Oncolytic Drugs

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 11, 2008-10 ,pp. : 1075-1087

Bentham Science Publishers

Access to resources Recommend Favorite

Protein-Tyrosine Phosphatase 1B (PTP1B): A Novel Therapeutic Target for Type 2 Diabetes Mellitus, Obesity and Related States of Insulin Resistance

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 1, Iss. 3, 2001-11 ,pp. : 265-275

Bentham Science Publishers

Access to resources Recommend Favorite